National Cancer Center Korea
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1989-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.ncc.re.kr
Clinical Trials
198
Active:7
Completed:75
Trial Phases
5 Phases
Phase 1:9
Phase 2:87
Phase 3:22
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (165 trials with phase data)• Click on a phase to view related trials
Phase 2
87 (52.7%)Not Applicable
45 (27.3%)Phase 3
22 (13.3%)Phase 1
9 (5.5%)Phase 4
2 (1.2%)Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer
Not Applicable
Recruiting
- Conditions
- Ovarian Cancer
- First Posted Date
- 2025-09-12
- Last Posted Date
- 2025-09-12
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 80
- Registration Number
- NCT07171528
- Locations
- 🇰🇷
National Cancer Center, Korea, Goyang-si, Gyeonggi-do, South Korea
Development & Clinical Application of K-PaC Registry Version 2.0
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2025-09-12
- Last Posted Date
- 2025-09-12
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 6923
- Registration Number
- NCT07171515
- Locations
- 🇰🇷
National Cancer Center, Goyang, Gyeonggido, South Korea
Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer
Not Applicable
Not yet recruiting
- Conditions
- Bladder CancerRadiation Cystitis
- First Posted Date
- 2025-08-15
- Last Posted Date
- 2025-08-15
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 54
- Registration Number
- NCT07125924
- Locations
- 🇰🇷
National Cancer Center, Korea, Goyang-si, Gyeonggi-do, Korea, Republic of
Patients With High-grade Pancreatic Neuroendocrine Tumors
Not Applicable
- Conditions
- Neuroendocrine Tumor of PancreasPancreatic Neuroendocrine Tumors
- Interventions
- First Posted Date
- 2025-08-13
- Last Posted Date
- 2025-10-01
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 46
- Registration Number
- NCT07121478
- Locations
- 🇰🇷
National Cancer Center, Goyang-si, Gyeonggi-do, South Korea
Knowledge-enhanced Digital Intervention to Prevent Low Anterior Resection Syndrome
Not Applicable
Not yet recruiting
- Conditions
- Rectal Neoplasm
- First Posted Date
- 2025-06-27
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 320
- Registration Number
- NCT07041515
- Prev
- 1
- 2
- 3
- 4
- 5
- 40
- Next
News
No news found